StockWatch: FDA Panel Enables Accelerated OK for Biogen ALS Drug

Mixed votes from an FDA advisory panel may help Biogen secure accelerated approval of ALS drug tofersen, licensed from Ionis Pharmaceuticals.

Related Keywords

Canada ,London ,City Of ,United Kingdom ,Canaccord Genuity ,Covis Pharma ,Zura Bio ,Tanabe Pharma America ,Marc Goodman ,Priya Singhal ,Eunk Yang ,Jonathan Wolleben ,Sumant Kulkarni ,European Medicines Agency ,Approval Program ,Reuters ,Pfizer ,Ionis Pharmaceuticals ,Biohaven Pharmaceuticals ,Amyotrophic Lateral Sclerosis ,Prescription Drug User Fee Act ,Accelerated Approval Program ,Under Accelerated Approval ,Combined Assessment ,Prilenia Therapeutics ,Seelos Therapeutics ,Mitsubishi Tanabe Pharma America ,Echo Lake Capital ,